Cas:57940-05-3 4,6,7-Trichloroquinazoline manufacturer & supplier

We serve Chemical Name:4,6,7-Trichloroquinazoline CAS:57940-05-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,6,7-Trichloroquinazoline

Chemical Name:4,6,7-Trichloroquinazoline
CAS.NO:57940-05-3
Synonyms:4,6,7-Trichloroquinazoline
Molecular Formula:C8H3Cl3N2
Molecular Weight:233.48200
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:25.78000
Exact Mass:231.93600
LogP:3.59000

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4,6,7-Trichloroquinazoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,6,7-Trichloroquinazoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,6,7-Trichloroquinazoline Use and application,4,6,7-Trichloroquinazoline technical grade,usp/ep/jp grade.


Related News: Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. 4,6,7-Trichloroquinazoline manufacturer Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23. 4,6,7-Trichloroquinazoline supplier Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23. 4,6,7-Trichloroquinazoline vendor Other possible health risks of PFAS include kidney cancer, testicular cancer and high blood pressure, the researchers added. 4,6,7-Trichloroquinazoline factory Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.